Biopharmaceutical company Agomab Therapeutics filed for an initial public ‌offering in the United ​States on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback